GLUE – monte rosa therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Assessing Monte Rosa Therapeutics (GLUE) Valuation After MRT-2359 Data Update And New Public Offering [Yahoo! Finance]
How Monte Rosa's MRT-2359 Prostate Cancer Data and Funding Plans Could Shape GLUE's Risk-Reward Profile [Yahoo! Finance]
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Form 4 Monte Rosa Therapeutics, For: Mar 04 Filed by: Dunn Edmund
Form 4 Monte Rosa Therapeutics, For: Mar 02 Filed by: Warmuth Markus
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Form 4 Monte Rosa Therapeutics, For: Feb 27 Filed by: Dunn Edmund
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.